ConductScience.org, home

Trial · NCT04226924

Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose

NCT04226924, Phase 2, Withdrawn, Bioblast Pharma Ltd.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose. Trials, record NCT04226924. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04226924

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
NCT number
NCT04226924
Status
Withdrawn
Phases
Phase 2
Enrollment
0 participants, actual
Lead sponsor
Bioblast Pharma Ltd.
Conditions
Oculopharyngeal Muscular Dystrophy
Interventions
Trehalose
First posted
2020-01-13
Last updated
2020-01-13

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDrinking Test Time24 weeksChange from baseline in timed drinking tests with 80 cc of ice-cold water and nectar.
SecondaryMuscle Strength Testing24 weeksChange from baseline in strength tests in selected muscle groups as measured by a handheld dynamometer
SecondaryStair Climb Test24 weeksChange from baseline in functional muscle testing as measured by the Stair Climb test
SecondaryTimed Up and Go Test24 weeksChange from baseline in functional muscle testing as measured by the Timed Up and Go (TUG) test
Secondary30-Second Lift Test24 weeksChange from baseline in functional muscle testing as measured by 30-Second Lift test
SecondaryEuroQol-5D-5L24 weeksChange from baseline in health status using the EuroQol-5D-5L Questionnaire
SecondarySwallowing Quality of Life24 weeksChange from baseline in quality of life using modified Swallowing Quality of Life Questionnaire
SecondarySydney Swallow Questionnaire24 weeksChange from baseline in quality of life using Sydney Swallow Questionnaire

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04226924

GET https://conductscience.org/api/trials/v1/NCT04226924/registered